PRESS RELEASE published on 09/27/2024 at 14:00, 2 years 1 month ago Sterling Organization Acquires Portfolio of Shopping Centers Totaling Almost One Million Square Feet for $180.5 Million Sterling Organization acquires three-property portfolio from SITE Centers worth $180.5 million, enhancing SVAP IV's shopping center portfolio with high-quality assets in prime markets Acquisition Real Estate Investment Sterling Organization Value-add Shopping Centers
PRESS RELEASE published on 09/27/2024 at 13:55, 2 years 1 month ago EQS-Adhoc: ZF Europe Finance B.V.: ZF changes forecast for financial year 2024 ZF Europe Finance B.V. adjusts forecast for financial year 2024 due to market decline and reassessment of risks, expecting lower earnings. Sales forecast lowered to EUR 40-42 billion with adjusted EBIT margin of 3-4 percent Forecast Adjustment Sales Forecast Market Decline ZF Europe Finance B.V. Earnings Expectations
PRESS RELEASE published on 09/27/2024 at 13:55, 2 years 1 month ago EQS-Adhoc: ZF Finance GmbH: ZF changes forecast for financial year 2024 ZF Finance GmbH adjusts forecast for financial year 2024 due to weak economy and market decline, lowering sales and earnings expectations Forecast Adjustment Financial Year 2024 Market Decline Earnings Expectations ZF Finance GmbH
PRESS RELEASE published on 09/27/2024 at 13:55, 2 years 1 month ago EQS-Adhoc: ZF North America Capital Inc.: ZF changes forecast for financial year 2024 ZF North America Capital Inc. adjusts forecast for 2024 due to market decline and lower earnings expectations, expecting Group sales EUR 40-42 billion, EBIT margin 3-4%, and free cash flow > EUR 100 million Forecast Adjustment Financial Year 2024 Market Decline Earnings Expectations ZF North America Capital Inc.
PRESS RELEASE published on 09/27/2024 at 13:40, 2 years 1 month ago United Terra Enterprises PLC Announces Results of Extraordinary Shareholders’ Meeting of Eurybia AG United Terra Enterprises PLC announces successful Eurybia AG shareholders' meeting with approvals for auditors, capital increase, and Articles updates Capital Increase Shareholders' Meeting United Terra Enterprises PLC Eurybia AG Articles Update
PRESS RELEASE published on 09/27/2024 at 13:30, 2 years 1 month ago MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 MIRA Pharmaceuticals presents preclinical results at Pain Therapeutics Summit showcasing that Ketamir-2 achieves 100% reversal of neuropathic pain. The innovative therapy targets NMDA receptors for enhanced efficacy Preclinical Results MIRA Pharmaceuticals Ketamir-2 NMDA Receptor Neuropathic Pain
PRESS RELEASE published on 09/27/2024 at 13:29, 2 years 1 month ago Changes in the Executive Board of Schaeffler AG Schaeffler AG announces changes in the Executive Board, with new appointments and roles effective from October 1, 2024, to align the company for the upcoming merger with Vitesco Technologies AG Appointments Executive Board Schaeffler AG Financial Officer E-Mobility Division
PRESS RELEASE published on 09/27/2024 at 13:00, 2 years 1 month ago Aston Bay and American West Metals Report 22.9m @ 8.5% Cu Intersected at the Storm Project, Nunavut, Canada Drill results show high-grade copper intersections at Storm Project, suggesting expansion potential. NEAS sealift operation saves $4M on 2025 budget High-grade Copper Expansion Potential Storm Project NEAS Sealift 2025 Budget
PRESS RELEASE published on 09/27/2024 at 13:00, 2 years 1 month ago Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China China COPD Dupixent Biologic Medicine Phase 3 Studies
PRESS RELEASE published on 09/27/2024 at 13:00, 2 years 1 month ago Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO, réduit les exacerbations et améliore la fonction respiratoire. Approbation suite à études de phase III Traitement Chine Approbation BPCO Dupixent
Published on 11/10/2026 at 08:00, 19 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 5 hours 34 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:00, 9 hours 19 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 9 hours 47 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/10/2026 at 08:00, 19 minutes ago Capital Markets Day: HENSOLDT confirms revenue ambition of 6 billion euros for 2030 and aims for 10 billion euros in 2035
Published on 11/10/2026 at 08:00, 19 minutes ago Deutsche Rohstoff AG: Invitation to the Q3 2026 webcast for investors, analysts and media
Published on 11/10/2026 at 07:50, 28 minutes ago From veranda to garden room: enjoy your garden all year round
Published on 11/10/2026 at 07:50, 29 minutes ago Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Published on 11/10/2026 at 07:00, 1 hour 19 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 1 hour 19 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 13 hours 49 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 13 hours 49 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF